In addition, CRLF1/CLCF1 reduced pulmonary fibrosis, and further investigation is needed to determine whether CRLF1 has therapeutic potential as an antifibrotic agent [119]. This evidence concerns the gene CRLF1 and pulmonary fibrosis.